Novel point mutation (W184R) in neonatal type 2 Gaucher disease

Area of Science:

• Genetics
• Biochemistry

Background:

• Gaucher disease is a prevalent inherited sphingolipidosis caused by deficient glucocerebrosidase activity.
• It presents in three clinical forms: type 1 (non-neuronopathic), type 2 (acute neuronopathic), and type 3 (subacute neuronopathic).

Observation:

• A novel heterozygous T --> C transition mutation (W184R) was identified in exon 6 of the glucocerebrosidase gene.
• This mutation creates a new Hinf1 restriction endonuclease cleavage site.
• The patient also carried the severe L444P mutation, common in types 2 and 3 Gaucher disease.

Findings:

• A new diagnostic method using Hinf1 restriction endonuclease analysis was developed to detect the W184R mutation.
• This method can be used to test family members for the mutation.
• The identified W184R/L444P genotype is associated with little to no glucocerebrosidase activity, indicating a poor prognosis.

Implications:

• This research provides a new tool for diagnosing Gaucher disease, particularly type 2.
• Understanding novel mutations like W184R enhances knowledge of glucocerebrosidase function and Gaucher disease pathogenesis.
• The findings contribute to predicting disease severity and prognosis based on genotype.